The transition from pediatric to adult care for patients with Lennox-Gastaut syndrome (LGS) is often hindered by fragmented planning and a lack of personalized support. As young adult patients move from home-based care to group homes, assisted living, or long-term …
A major hurdle in managing type 2 diabetes (T2D) is a widespread gap in clinician awareness around the powerful, far-reaching benefits of GLP-1 receptor agonists (GLP-1 RAs). These innovative therapies help reduce the burden of cardiovascular, kidney, and metabolic (CKM) …
Clinicians face considerable hurdles when diagnosing and managing narcolepsy and idiopathic hypersomnia (IH), largely due to overlapping symptoms, insufficient formal training in sleep medicine, and limited recognition of associated psychiatric and cardiometabolic comorbidities. Compounding the challenge, some therapeutic agents—most notably …
Pre-exposure prophylaxis (PrEP) is an established and highly effective method of preventing sexually transmitted human immunodeficiency virus (HIV) infections and has been instrumental in declining incidence rates. Adherence and access to HIV prevention still pose challenges due to stigma and …
Pre-exposure prophylaxis (PrEP) is an established and highly effective method of preventing sexually transmitted human immunodeficiency virus (HIV) infections and has been instrumental in declining incidence rates. Adherence and access to HIV prevention still pose challenges due to stigma and …
OVERVIEW Rheumatologists, pulmonologists, NPs, PAs, fellows and residents who have been in practice for less than 10 years with an interest in interstitial lung diseases (ILDs) are invited to attend the 2025 Early Career Professional Program on Interstitial Lung Disease (ECPP-ILD). …
Traditional diagnosis and treatment of Alzheimer’s disease (AD) has relied heavily on the clinical expertise of healthcare professionals (HCPs) and patient-reported symptoms. However, recently revised diagnostic criteria incorporate biomarkers—such as amyloid and tau pathology—and advanced imaging modalities, including amyloid, tau, …
Traditional diagnosis and treatment of Alzheimer’s disease (AD) has relied heavily on the clinical expertise of healthcare professionals (HCPs) and patient-reported symptoms. However, recently revised diagnostic criteria incorporate biomarkers—such as amyloid and tau pathology—and advanced imaging modalities, including amyloid, tau, …
Generalized myasthenia gravis (gMG) is a chronic neuromuscular disorder that results from destruction of the neuromuscular junction by pathogenic autoantibodies, partially through the actions of the neonatal Fc receptor (FcRn). Traditional therapies only partially alleviate the heavy disease burden and …